LABT logo

Lakewood-Amedex Biotherapeutics, Inc.

LABT
Healthcare|Biotechnology|US
$0.39
-0.15 (-28.54%)
Tangible Book / Share
$3.05
Cash / Share
$3.23

Ownership Breakdown

16.2%
Float
1.8M
Shares Outstanding
0.3M
Float Shares

Major Holders (3)

Combined: 42.7%

Holders of 5%+ from their latest Schedule 13D/13G filing in the last two years. Percentages are as of each filing date.

HolderType% of ClassSharesFiledFiling
HPW Investments Holding Ltd.Corporation24.04%3,435,501Jun 23, 202613D/G
Lindesfarne LLCOther9.88%203,360Aug 6, 202613D/G
WFI Equity, LLCOther8.80%1,259,684Aug 14, 202613D/G

Insider Trades (18)

InsiderPositionDateTypeSharesPriceValueFiling
Tucker Joseph EdwarddirectorApr 24, 2026AWARD33,784$10.00$337.8KForm 4
Tucker Joseph EdwarddirectorApr 24, 2026OTHER0——Form 4
DeRoma Leonard JamesdirectorApr 17, 2026OTHER0——Form 4
DeRoma Leonard JamesdirectorJan 12, 2018OTHER33,784$5.92$200.0KForm 4
DeRoma Leonard JamesdirectorJul 12, 2020OTHER8,446$2.37$20.0KForm 4
DeRoma Leonard JamesdirectorJul 12, 2021OTHER8,446$2.78$23.5KForm 4
DeRoma Leonard JamesdirectorJul 12, 2022OTHER8,446$2.13$18.0KForm 4
Balzer ThomasChief Medical OfficerApr 17, 2026OTHER0——Form 4
Balzer ThomasChief Medical OfficerMar 14, 2025OTHER46,115$2.13$98.2KForm 4
Balzer ThomasChief Medical OfficerJul 2, 2025OTHER168,919$2.31$390.2KForm 4
Cooper Kelvindirector, officer: Chief Executive OfficerApr 17, 2026OTHER0——Form 4
Cooper Kelvindirector, officer: Chief Executive OfficerNov 1, 2025OTHER13,514$2.78$37.6KForm 4
Cooper Kelvindirector, officer: Chief Executive OfficerAug 1, 2024OTHER72,467$2.13$154.4KForm 4
Cooper Kelvindirector, officer: Chief Executive OfficerJul 2, 2025OTHER202,703$2.31$468.2KForm 4
Ceccacci PeterChief Financial OfficerApr 17, 2026OTHER0——Form 4
Ceccacci PeterChief Financial OfficerMar 1, 2022OTHER33,784$2.78$93.9KForm 4
Ceccacci PeterChief Financial OfficerMar 14, 2025OTHER29,561$2.13$63.0KForm 4
Ceccacci PeterChief Financial OfficerJul 2, 2025OTHER202,703$2.31$468.2KForm 4